| scholarly article | Q13442814 |
| P2093 | author name string | Anne J Novak | |
| Stephen M Ansell | |||
| Lucy S Hodge | |||
| Zhi-Zhang Yang | |||
| Steven C Ziesmer | |||
| Frank J Secreto | |||
| P2860 | cites work | Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis. | Q46987226 |
| Constitutive activation of Stat5 promotes its cytoplasmic localization and association with PI3-kinase in myeloid leukemias | Q58029666 | ||
| Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration | Q80638835 | ||
| Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma | Q80732588 | ||
| STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells | Q24534351 | ||
| Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins | Q27860890 | ||
| Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses | Q28592023 | ||
| Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells | Q30439082 | ||
| Discovery of chromone-based inhibitors of the transcription factor STAT5. | Q33318036 | ||
| Mutational switch of an IL-6 response to an interferon-gamma-like response | Q34031049 | ||
| Stat5a/b are essential for normal lymphoid development and differentiation | Q34253065 | ||
| STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression. | Q34985773 | ||
| Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia | Q35213566 | ||
| Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity | Q35553334 | ||
| Differential function of STAT5 isoforms in head and neck cancer growth control | Q38289837 | ||
| Constitutive activation of the JAK2/STAT5 signal transduction pathway correlates with growth factor independence of megakaryocytic leukemic cell lines | Q38326792 | ||
| Constitutive activation of Stat5b contributes to carcinogenesis in vivo | Q38348600 | ||
| IL-21 in the bone marrow microenvironment contributes to IgM secretion and proliferation of malignant cells in Waldenstrom macroglobulinemia | Q39278952 | ||
| Novel indoloquinoline derivative, IQDMA, inhibits STAT5 signaling associated with apoptosis in K562 cells | Q46181906 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 4 | |
| P304 | page(s) | 1055-1058 | |
| P577 | publication date | 2013-12-11 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Constitutive activation of STAT5A and STAT5B regulates IgM secretion in Waldenstrom's macroglobulinemia | |
| P478 | volume | 123 |
| Q40858735 | Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker. |
| Q27021855 | Factors regulating immunoglobulin production by normal and disease-associated plasma cells |
| Q38723769 | Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells |
| Q38542260 | Ibrutinib for the treatment of Waldenström macroglobulinemia |
| Q28546079 | Methotrexate Is a JAK/STAT Pathway Inhibitor |
| Q53087536 | Phospho-flow detection of constitutive and cytokine-induced pSTAT3/5, pAKT and pERK expression highlights novel prognostic biomarkers for patients with multiple myeloma. |
Search more.